| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute stroke and cytomegalovirus encephalitis: a coincidence?
|
Harzheim, Michael
|
|
2010
|
|
5 |
p. 323-325
|
artikel
|
| 2 |
Anti-aquaporin-4 antibodies in Devic’s neuromyelitis optica: therapeutic implications
|
Marignier, Romain
|
|
2010
|
|
5 |
p. 311-321
|
artikel
|
| 3 |
An update on the treatment of Sydenham’s chorea: the evidence for established and evolving interventions
|
Walker, Kathleen G.
|
|
2010
|
|
5 |
p. 301-309
|
artikel
|
| 4 |
A review of the high-concentration capsaicin patch and experience in its use in the management of neuropathic pain
|
Baranidharan, Ganesan
|
|
2013
|
|
5 |
p. 287-297
|
artikel
|
| 5 |
Chemotherapeutics in the treatment of multiple sclerosis
|
Kieseier, Bernd C.
|
|
2010
|
|
5 |
p. 277-291
|
artikel
|
| 6 |
Children with multiple sclerosis should not become therapeutic hostages
|
Rose, Klaus
|
|
2016
|
|
5 |
p. 389-395
|
artikel
|
| 7 |
Combination treatment of fingolimod with antidepressants in relapsing–remitting multiple sclerosis patients with depression: a multicentre, open-label study – REGAIN
|
Bayas, Antonios
|
|
2016
|
|
5 |
p. 378-388
|
artikel
|
| 8 |
Complementary and alternative interventions for fatigue management after traumatic brain injury: a systematic review
|
Xu, Gang-Zhu
|
|
2017
|
|
5 |
p. 229-239
|
artikel
|
| 9 |
Diagnosis and management of central hypersomnias
|
Sonka, Karel
|
|
2012
|
|
5 |
p. 297-305
|
artikel
|
| 10 |
Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing–remitting multiple sclerosis
|
Boster, Aaron
|
|
2011
|
|
5 |
p. 319-332
|
artikel
|
| 11 |
Eletriptan in the management of acute migraine: an update on the evidence for efficacy, safety, and consistent response
|
Capi, Matilde
|
|
2016
|
|
5 |
p. 414-423
|
artikel
|
| 12 |
Evaluation of positive and negative predictors of seizure outcomes among patients with immune-mediated epilepsy: a meta-analysis
|
Dubey, Divyanshu
|
|
2016
|
|
5 |
p. 369-377
|
artikel
|
| 13 |
Extended interval dosing of natalizumab: a two-center, 7-year experience
|
Bomprezzi, Roberto
|
|
2014
|
|
5 |
p. 227-231
|
artikel
|
| 14 |
Fumarate treatment in progressive forms of multiple sclerosis: first results of a single-center observational study
|
Strassburger-Krogias, Katrin
|
|
2014
|
|
5 |
p. 232-238
|
artikel
|
| 15 |
Herpesvirus infections of the central nervous system in immunocompromised patients
|
Meyding-Lamadé, Uta
|
|
2012
|
|
5 |
p. 279-296
|
artikel
|
| 16 |
Implementation of computer-based language therapy in aphasia
|
Archibald, Lisa M.D.
|
|
2009
|
|
5 |
p. 299-311
|
artikel
|
| 17 |
Intracranial aneurysms: optimized diagnostic tools call for thorough interdisciplinary treatment strategies
|
Mueller, Oliver M.
|
|
2011
|
|
5 |
p. 267-279
|
artikel
|
| 18 |
Isoniazid in autoimmunity: a trigger for multiple sclerosis?
|
Nourbakhsh, Bardia
|
|
2014
|
|
5 |
p. 253-256
|
artikel
|
| 19 |
Long-term daclizumab therapy in relapsing-remitting multiple sclerosis
|
Rojas, Monica A.
|
|
2009
|
|
5 |
p. 291-297
|
artikel
|
| 20 |
Magnetic resonance monitoring of lesion evolution in multiple sclerosis
|
Rovira, Àlex
|
|
2013
|
|
5 |
p. 298-310
|
artikel
|
| 21 |
Multiple sclerosis and pregnancy: experience from a nationwide database in Germany
|
Hellwig, Kerstin
|
|
2012
|
|
5 |
p. 247-253
|
artikel
|
| 22 |
Natalizumab in pediatric multiple sclerosis patients
|
Yeh, E. Ann
|
|
2010
|
|
5 |
p. 293-299
|
artikel
|
| 23 |
Novel oral anticoagulants for the secondary prevention of cerebral ischemia: a network meta-analysis
|
Katsanos, Aristeidis H.
|
|
2016
|
|
5 |
p. 359-368
|
artikel
|
| 24 |
Percutaneous transluminal angioplasty and stenting for symptomatic intracranial arterial stenosis: a systematic review and meta-analysis
|
Tsivgoulis, Georgios
|
|
2016
|
|
5 |
p. 351-358
|
artikel
|
| 25 |
Poststroke epilepsy: update and future directions
|
Zelano, Johan
|
|
2016
|
|
5 |
p. 424-435
|
artikel
|
| 26 |
Response of patients with refractory myasthenia gravis to rituximab: a retrospective study
|
Nowak, Richard J.
|
|
2011
|
|
5 |
p. 259-266
|
artikel
|
| 27 |
Response to Sheehan, B. (2012) Assessment scales in dementia. Ther Adv Neurol Disord 5: 349–358
|
Volicer, Ladislav
|
|
2013
|
|
5 |
p. 337-338
|
artikel
|
| 28 |
Review: A review of the use of zonisamide in Parkinson’s disease
|
Bermejo, Pedro Emilio
|
|
2009
|
|
5 |
p. 313-317
|
artikel
|
| 29 |
Review: Depression in epilepsy: mechanisms and therapeutic approach
|
Mula, Marco
|
|
2009
|
|
5 |
p. 337-344
|
artikel
|
| 30 |
Review: Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials
|
Ludolph, Albert C.
|
|
2009
|
|
5 |
p. 319-326
|
artikel
|
| 31 |
Review: Menstrual migraine: therapeutic approaches
|
MacGregor, E. Anne
|
|
2009
|
|
5 |
p. 327-336
|
artikel
|
| 32 |
Sumatriptan/naproxen sodium combination versus its components administered concomitantly for the acute treatment of migraine: a pragmatic, crossover, open-label outcomes study
|
Landy, Stephen
|
|
2013
|
|
5 |
p. 279-286
|
artikel
|
| 33 |
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity
|
Leussink, Verena Isabell
|
|
2012
|
|
5 |
p. 255-266
|
artikel
|
| 34 |
Targeting ion channels for the treatment of autoimmune neuroinflammation
|
Bittner, Stefan
|
|
2013
|
|
5 |
p. 322-336
|
artikel
|
| 35 |
Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospects
|
Oh, Jiwon
|
|
2014
|
|
5 |
p. 239-252
|
artikel
|
| 36 |
The interferon beta therapies for treatment of relapsing–remitting multiple sclerosis: are they equally efficacious? A comparative review of open-label studies evaluating the efficacy, safety, or dosing of different interferon beta formulations alone or in combination
|
Limmroth, Volker
|
|
2011
|
|
5 |
p. 281-296
|
artikel
|
| 37 |
The physiological basis of therapies for cerebellar ataxias
|
Mitoma, Hiroshi
|
|
2016
|
|
5 |
p. 396-413
|
artikel
|
| 38 |
Therapeutic advances in the management of Pompe disease and other metabolic myopathies
|
Angelini, Corrado
|
|
2013
|
|
5 |
p. 311-321
|
artikel
|
| 39 |
Therapeutic potential of melatonin and its analogs in Parkinson’s disease: focus on sleep and neuroprotection
|
Srinivasan, Venkatramanujam
|
|
2011
|
|
5 |
p. 297-317
|
artikel
|
| 40 |
The use of gabapentin enacarbil in the treatment of restless legs syndrome
|
Yaltho, Toby C.
|
|
2010
|
|
5 |
p. 269-275
|
artikel
|
| 41 |
Under-representation of women in stroke randomized controlled trials: inadvertent selection bias leading to suboptimal conclusions
|
Tsivgoulis, Georgios
|
|
2017
|
|
5 |
p. 241-244
|
artikel
|
| 42 |
Usefulness of optical coherence tomography to distinguish optic neuritis associated with AQP4 or MOG in neuromyelitis optica spectrum disorders
|
Martinez-Lapiscina, Elena H.
|
|
2016
|
|
5 |
p. 436-440
|
artikel
|
| 43 |
White matter dementia
|
Filley, Christopher M.
|
|
2012
|
|
5 |
p. 267-277
|
artikel
|
Tijdschrift beschrijving